Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity.

<h4>Background</h4>Several Chlamydia pneumoniae (Cp) biomarkers have been associated with asthma but Cp-specific IgE (Cp IgE) has not been investigated extensively. Our objective was to investigate Cp IgE in community adult asthma patients.<h4>Methods</h4>(1) Prevalence of Cp...

Full description

Bibliographic Details
Main Authors: David L Hahn, Allison Schure, Katir Patel, Tawanna Childs, Eduard Drizik, Wilmore Webley
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22545149/pdf/?tool=EBI
_version_ 1818744113546133504
author David L Hahn
Allison Schure
Katir Patel
Tawanna Childs
Eduard Drizik
Wilmore Webley
author_facet David L Hahn
Allison Schure
Katir Patel
Tawanna Childs
Eduard Drizik
Wilmore Webley
author_sort David L Hahn
collection DOAJ
description <h4>Background</h4>Several Chlamydia pneumoniae (Cp) biomarkers have been associated with asthma but Cp-specific IgE (Cp IgE) has not been investigated extensively. Our objective was to investigate Cp IgE in community adult asthma patients.<h4>Methods</h4>(1) Prevalence of Cp IgE (measured by immunoblotting) and Cp DNA (by polymerase chain reaction) in peripheral blood, and biomarker associations with asthma severity. (2) Case-control studies of Cp IgE association with asthma using healthy blood donor (study 1) and non-asthmatic clinic patient (study 2) controls.<h4>Results</h4>Of 66 asthma subjects (mean age 40.9 years, range 5-75, 59% male, 45% ever-smokers) 33 (50%) were Cp IgE positive and 16 (24%) were Cp DNA positive (P = 0.001 for association of Cp IgE and DNA). Cp IgE was detected in 21% of mild intermittent asthma v 79% of severe persistent asthma (test for trend over severity categories, P = 0.002). Cp IgE detection was significantly (P = 0.001) associated with asthma when compared to healthy blood donor controls but not when compared to clinic controls.<h4>Conclusions</h4>Half of this sample of community asthma patients had detectable IgE against C. pneumoniae. Cp IgE was strongly and positively associated with asthma severity and with asthma when healthy blood donor controls were used. These results support the inclusion of Cp IgE as a biomarker in future studies of infectious contributions to asthma pathogenesis.
first_indexed 2024-12-18T02:39:09Z
format Article
id doaj.art-7210eaf058d44e42b1c01a06f2bc703f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-18T02:39:09Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-7210eaf058d44e42b1c01a06f2bc703f2022-12-21T21:23:43ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0174e3594510.1371/journal.pone.0035945Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity.David L HahnAllison SchureKatir PatelTawanna ChildsEduard DrizikWilmore Webley<h4>Background</h4>Several Chlamydia pneumoniae (Cp) biomarkers have been associated with asthma but Cp-specific IgE (Cp IgE) has not been investigated extensively. Our objective was to investigate Cp IgE in community adult asthma patients.<h4>Methods</h4>(1) Prevalence of Cp IgE (measured by immunoblotting) and Cp DNA (by polymerase chain reaction) in peripheral blood, and biomarker associations with asthma severity. (2) Case-control studies of Cp IgE association with asthma using healthy blood donor (study 1) and non-asthmatic clinic patient (study 2) controls.<h4>Results</h4>Of 66 asthma subjects (mean age 40.9 years, range 5-75, 59% male, 45% ever-smokers) 33 (50%) were Cp IgE positive and 16 (24%) were Cp DNA positive (P = 0.001 for association of Cp IgE and DNA). Cp IgE was detected in 21% of mild intermittent asthma v 79% of severe persistent asthma (test for trend over severity categories, P = 0.002). Cp IgE detection was significantly (P = 0.001) associated with asthma when compared to healthy blood donor controls but not when compared to clinic controls.<h4>Conclusions</h4>Half of this sample of community asthma patients had detectable IgE against C. pneumoniae. Cp IgE was strongly and positively associated with asthma severity and with asthma when healthy blood donor controls were used. These results support the inclusion of Cp IgE as a biomarker in future studies of infectious contributions to asthma pathogenesis.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22545149/pdf/?tool=EBI
spellingShingle David L Hahn
Allison Schure
Katir Patel
Tawanna Childs
Eduard Drizik
Wilmore Webley
Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity.
PLoS ONE
title Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity.
title_full Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity.
title_fullStr Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity.
title_full_unstemmed Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity.
title_short Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity.
title_sort chlamydia pneumoniae specific ige is prevalent in asthma and is associated with disease severity
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22545149/pdf/?tool=EBI
work_keys_str_mv AT davidlhahn chlamydiapneumoniaespecificigeisprevalentinasthmaandisassociatedwithdiseaseseverity
AT allisonschure chlamydiapneumoniaespecificigeisprevalentinasthmaandisassociatedwithdiseaseseverity
AT katirpatel chlamydiapneumoniaespecificigeisprevalentinasthmaandisassociatedwithdiseaseseverity
AT tawannachilds chlamydiapneumoniaespecificigeisprevalentinasthmaandisassociatedwithdiseaseseverity
AT eduarddrizik chlamydiapneumoniaespecificigeisprevalentinasthmaandisassociatedwithdiseaseseverity
AT wilmorewebley chlamydiapneumoniaespecificigeisprevalentinasthmaandisassociatedwithdiseaseseverity